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Introduction
Coronary heart disease (CHD) is a disease 
caused by plaque that has accumulated in 
the lumen of the coronary arteries, leading 
to a limited supply of oxygen to the heart 
muscle.1-3 The CHD is one of the most common 
cardiovascular diseases, a disorder of the heart 
and blood vessels including stroke, rheumatic 
heart disease, and other conditions.4 According 
to world statistics, there are 9.4 million 
deaths each year caused by cardiovascular 
disease, and 45% of these deaths are caused 
by CHD. It is estimated that the number will 
increase to 23.6 million in 2030.4,5 In 2013, 
the highest prevalence for cardiovascular 
disease in Indonesia is CHD. The incidence of 
CHD is mainly found in the age between 65–
74 years (3.6%) followed by the age group of 
75 years and above (3.2%), the age group of 
55–64 years (2.1%), and the age group 35–44 
years old (1.3%).6 Dr. Hasan Sadikin General 
Hospital Bandung has handled the cases of 
CHD in 2017 as many as 764 outpatients and 
3836 inpatients, with the incidence of male 
patients more than women, a ratio of 4:1.7
The development of atherosclerosis is 
started with the formation of foam cells that 
are induced by chronic hyperlipidemia, namely 
excessive fat intake in a long time.8 Epicardial 
fat can affect the formation of coronary 
atherosclerosis due to the absence of a fibro 
fascia layer that is able to inhibit the diffusion of 
free fatty acids and adipokines from epicardial 
fat to the walls of the blood vessels and 
surrounding heart muscle.9 The accumulation 
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Abstract
Background: Coronary heart disease (CHD) is a disease that raises public health concerns due to 
its high morbidity and mortality rates. Anatomically, epicardial fat is located around the heart and 
coronary system, making it important in the development of coronary atherosclerosis. This study 
aimed to explore the relationship between epicardial fat volume (EFV) and the type of coronary artery 
plaque by using Cardiac Computed Tomoghraphy (CT)-Scan.
Methods: This was a cross-sectional observational analytic study on patients diagnosed with CHD 
aged > 20 years who had undergone cardiac CT-Scan at the Department of Radiology, Dr. Hasan Sadikin 
General Hospital, Bandung, Indonesia between February and June 2019. Data collected from the CT-
Scan were analyzed using the Chi-square test.
Results: From 54 CHD patients, consisting of an equal number of male and female patients, with a 
majority of above 60 years old (31.5%), a correlation was identified between increased amount of 
EFV and mix and hard plaques in the right cirumflex artery (RCA) (p<0.026) and left circumflex (LCX) 
(p<0.038)On the left main(LM) and left anterior descending (LAD) arteries, no significant correlation 
was observed between EFV and the type of plaque (p>0.05).
Conclusions: There is a significant relationship between the EFV value, EFV category, and the type 
of coronary artery plaque in CHD patients in RCA and LCX arteries. However, this correlation is not 
observed in LM and LAD arteries.
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of epicardial fat increases the secretion of 
local inflammatory mediator that triggers 
atherosclerotic processes and other systemic 
effects.9,10 Previous studies have shown that 
increased epicardial fat volume (EFV) might 
progress into coronary atherosclerosis in 
the near to medium term with an average 
of 2.7/year).10 The thickening of epicardial 
adipose tissue should be considered as a 
more accurate risk factor in cardiovascular 
disease.11 Hence, it is a potential therapeutic 
target, as well as an examination target that 
shows an association between epicardial fat 
and coronary heart disease by using a cardiac 
computed tomography (CT)scan. CT-scan is 
more accurate in measuring the accumulation 
of adipose tissue or epicardial fat due to higher 
spatial resolution.11
Measurement of EFV can be performed 
using several imaging modalities such as 
echocardiography, cardiac CT-scan with Multi 
Sliced Computed Tomography (MSCT), and 
Magnetic Resonance Imaging (MRI). The EFV 
measurement using a cardiac CT-scan with 
or without contrast is conducted manually 
by tracing the epicardial layer in each piece 
from the appendix atrium to the heart apex. 
The thickness of epicardial fat is identified 
by Hounsfield Units (HU) which is set at -250 
to -30, then the computer measures EFV 
automatically.12,13 Another study has shown 
the normal EFV value <125 ml. Value >125 ml 
is considered not normal, however, EFV>100 
ml is able to estimate CHD.12
Epicardial fat has a role in atherosclerosis, 
an increase in epicardial fat volume has a 
relationship with the type of plaque without 
calcification and plaque with a mixture 
of calcifications that cause stenosis in the 
coronary artery lumen.13 The influence of 
epicardial fat volume on the degree of severe 
coronary artery stenosis is mainly due to soft 
plaque and mix plaque-type atherosclerosis.14
Epicardial fat tissue contributes to the 
pathogenesis of coronary atherosclerosis. 
Atherosclerotic plaques are classified into 
calcified, non-calcified, and mixed lesions. 
The attenuation assessment of HU ≥130 is 
considered the type of calcification. A cardiac 
CT-scan analysis has shown that calcified 
plaque if at least 0.5 mm2 in the identified area 
diameter has a density ≥130 HU.15 Furthermore, 
uncalcified plaques are divided into 2 based 
on Hounsfield unit (HU) values, which are 
low plaque (HU 0-49) that is considered to be 
lipid-rich plaques, and medium (HU 50-129) is 
considered fibrous-rich plaques.15 In plaques 
that show calcification ≤50% of the plaque 
area is classified as a mixture.12 Since research 
on the relationship of coronary artery plaque 
Iman Imaduddin Robandi et al.: Type of Coronary Artery Plaque in Relation to Epicardial Fat Volume in 
Coronary Heart Disease Patients: A Cardiac Computed Tomography Scan Study
Figure 1 Assessment of The Type of Coronary Artery Plaque
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types with epicardial fat volume in patients 
with coronary heart disease using a CT scan of 
the heart has never been done in the Dr. Hasan 
SadikinGeneral Hospital Bandung, this study 
aimed to find the relationship of coronary 
artery plaque types with epicardial fat volume 
in patients with coronary heart disease using a 
CT scan of the heart.
Methods
This study was an observational analytic study 
with a cross-sectional design, conducted in 
patients with CHD. The CHD patients aged >20 
years old, who underwent cardiac CT Scan at 
Dr. Hasan Sadikin General Hospital Bandung 
from February to June 2019 were recruited. 
This study measured epicardial fat volume 
(EFV) and the type of coronary artery plaque 
based on calcification formed. This study was 
approved by the Ethical Committee of Dr. 
Hasan Sadikin General Hospital Bandung with 
the number LB.02.01/X.6.5/111/2019.
In brief, cardiac 128-slice CT scans 
(The Scenaria SE, Hitachi Healthcare) was 
used, consisting of Digital Imaging and 
Communication in Medicine (DICOM) data. 
Aquarius iNtuition client ver.4.4.12.196.3577 
post-processing workstation, Terarecon 
software, Terarecon CT-cardiac workflow 
Software Terarecon-Aquarius iNtuition 
client ver. 4.4.12.196.3577, Terarecon 3D Fat 
Analysis. Trace data on the results of the CT-
scan of the heart i.e. the type of plaque on 
the coronary arteries (Figure 1) and the FEV 
(Figure 2).
The assessment of coronary artery stenosis 
by reconstructing DICOM data using Terarecon 
software, CT-Cardiac Analysis Workflow that 
made a reconstruction of volume rendering 
technique (VRT), multi planar reformation 
(MPR), curved planar reformation (CPR), then 
the amount of stenosis in each branch of the 
coronary arteries i.e. right circumflex artery 
(RCA), left circumflex (LCX) artery, left ain 
(LM) artery left anterior descending (LAD) 
artery was assessed.
Coronary artery stenosis was caused by 
atherosclerotic plaque lesions in the form 
of calcified, non-calcified, or mixed plaque. 
Quantitative measurement of plaque types 
was measured using plaque analysis methods 
by assessing the hounsfield units (HU). The 
coronary CT-scan images were analyzed 
using an image archiving and communication 
system. If an abnormal segment was identified, 
the coronary artery was evaluated using the 
Aquarius Workstation (TeraRecon, San Mateo, 
CA) and the non-calcified plaque volume was 
measured. Categories based on CT (HU) value: 
low (HU 0–49; considered plaque rich in fat) 
and moderate attenuation composition (HU 
50–129; considered as fibrous plaque). The 
plaque was color-coded and the volume of 
Figure 2 Assessment of Epicardial Fat Volume 
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each component was measured. The color-
coded area was manually adjusted, including 
the thickness of the blood vessel wall, and the 
surrounding tissue is eliminated. A 2 Curved 
multiplanar reconstructing baselines and 
follow-up CT were displayed in parallel and 
then identical segments were compared side 
by side using the Aquarius workstation.15
As for the EFV measurement procedure, 
Terarecon-Aquarius iNtuition client software 
ver. 4.4.12.196.3577, Terarecon 3D Fat 
Analysis was used. With the semi-automatic 
method on axial pieces with a thickness of 
1–3 mm, it was done manually by tracing the 
epicardial layer in each cut from the appendix 
to the atrium of the heart. Epicardial adipose 
tissue was identified by Hounsfield units (HU) 
which were set at -250 to -30, then EFV was 
then automatically measured by the computer. 
The epicardial fat volume (EFV) data was 
then categorized as normal and abnormal. 
Epicardial fat was identified as a hypodense 
lesion that surrounded the myocardium and 
was bounded by the pericardium
The EFV data normality test was conducted 
with the Saphiro Wilk test (n=54) and data 
was normal distributed if the value of p> 
0.05. The bivariate analysis aimed to examine 
the relationship of EFV with the degree of 
coronary artery stenosis, using the ANOVA test 
if the EFV data were normally distributed, or 
the KruskallWallist Test if the EFV data were 
not normally distributed. Data analysis was 
performed using the Statistical Product and 
Service Solution (SPSS) program for Windows 
version 18.0.
Results
Of 54 CHD patients, that were equally 
distributed in gender, the majority was aged 
above 60 years (31.5%). The majority had 
a volume of epicardial fat detected >125 ml 
which was categorized as abnormal. The 
average value of fraction ejection was 49.33 
range 13.92–88.49). The average of calcium 
score was 398.72 (range 0–4778).
There was a significant relationship in 
the value and category of EFV with the type 
of coronary artery plaque in CHD patients. 
It was not all plaque collection sites had the 
same results. In RCA and LCX, plaque type 
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Table 1 Characteristics of Patients with Coronary Heart Disease from Dr. Hasan Sadikin 
General Hospital
Characteristics Total (n) Percentage (%)
Gender
     Male 27 50.0
     Female 27 50.0
Age (Years)
     ≤30 4 7.4
     31-40 6 11.1
     41-50 12 22.2
     51-60 15 27.8
     >60 17 31.5
Epicardial Fat Volume
     Normal <125 mL 17 31.5
     Abnormal >125 mL 37 68.5
Ejection Fraction
     Averange±SD 49.33±18.81
     Median (Min-Max) 52.58 (13.92–88.49)
Calcium Score
     Averange±SD 398.72±776.30
     Median (Min-Max) 65.10 (0.0–4778)
Althea Medical Journal. 2020;7(3)
146     AMJ September 2020
and epicardial fat volume had a significant 
correlation with p=0.026 and p=0.038, 
respectively. In contrast, in the LM and LAD, 
no significant different between the type of 
plaque and epicardial fat volume (Table 2).
Discussions
This study shows the characteristics of 
patients with coronary heart disease (CHD) 
of whom the relationship has been analyzed 
between the epicardial fat volume (EFV), and 
the type of plaque in the coronary arteries. 
Interestingly, measurement of epicardial 
fat volume carried out at the workstation 
as described by Gorteret al. in Bertaso et al. 
did not reveal the assessment of the visceral 
layer of the pericardium.13 It was carried out 
manually from the center of the left atrium 
to the top of the left ventricle, and all extra-
pericardial tissue was eliminated. The images 
then segmented using attenuation thresholds 
that vary between −250 HU and −30 HU so 
that they depict the epicardial fat portion in 
each slice. This did not include myocardium, 
coronary arteries, coronary calcium, aorta, 
and blood clusters. The epicardial fat area at 
each level was added across the slices and 
multiplied by the thickness of the slices and 
the number of slices to determine the total 
epicardial fat volume (Figure 2). This method 
is also used to measure epicardial fat volume 
reported by Alexopoulos et al.13
Age distribution ranges from 30 years to 80 
years. This is adjusted to the inclusion criteria 
taken. The age characteristics of the subjects of 
this study are in accordance with 2015 Heart 
Disease and Stroke Heart Disease statistical 
data which states the prevalence of CHD in the 
United States starting from age >20 years and 
the coronary artery atherosclerosis process 
begins to emerge in the second decade of life. 
The age distribution and the amount of 
epicardial fat volume have a bearing on the 
potential for coronary atherosclerosis, so in this 
case, it is directly proportional to the increase 
in the increase in the calcium score. There is 
conformity with the types of soft plaque, mix 
plaque, and hard plaque. This study found the 
results of coronary compliance in RCA and LCX 
patients who have epicardial volume values of 
more than 125 ml have a correlation with the 
type of mix plaque and hard plaque. 
The majority of CHD patients in our study 
was aged above 60 years with a percentage 
of 31.5%, however, there was also an age 
over 30 years have significant value (Table1). 
The volume of epicardial fat detected is 
predominantly above 125 ml which is included 
in the abnormal category (n=37) that directly 
proportional to the average age above 60 
years affected by CHD. The average of fraction 






Soft 3 (37.5%) 5 (62.5%) 8 (100%) 0.026*
Hard 5 (17.2%) 24 (82.8% 29 (100%)
Mix 9 (56.3%) 7 (43.8%) 16 (100%)
LM
Soft 2 (25.0%) 6 (75,0%) 8 (100%) 0.802
Hard 2 (14.3%) 12 (85.7%) 14 (100%)
Mix 2 (22.2%) 7 (77.7%) 9 (100%)
LAD
Soft 1 (100.0%) 0 (0.0%) 1 (100%) 0.183
Hard 6 (22.2%) 21 (77.8%) 27 (100%)
Mix 8 (34.8%) 15 (65.2%) 23 (100%)
LCX
Soft 6 (60.0%) 4 (40.0%) 10 (100%) 0.038*
Hard 3 (15.0%) 17 (85.0%) 20 (100%)
Mix 6 (28.6%) 15 (71.4%) 21 (100%)  
Note: RCA= right circumflex artery, LM= left main, LAD= left anterior descending, LCX= left circumflex. * was statistically 
significant p<0.05
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ejection is 49.33 (range 13.92–88.49) and the 
average of calcium score is 398.72 with a wide 
range (0–4778).
The average volume of epicardial fat 
found in population-based studies ranged 
from 68±34 ml to 124±50 ml. In a study 
including patients from the Framingham 
group, the average volume of epicardial fat 
was 110±41 ml in women and 137±53 ml in 
men.16 Epicardial fat is a deposit of visceral fat 
which partly shares its metabolic and systemic 
inflammatory effects so that it has an effect 
on the wall coronary arteries. Epicardial fat 
is consistently associated with metabolic 
syndrome and coronary heart disease. 
According to current knowledge, EF thickness 
>5 mm, or volume >125 ml or 68 ml/m² are 
considered abnormal.16
In accordance with data from the Ministry of 
Health Republic of Indonesia in 2013, Bertaso 
et al.16 has suggested that the normal EFV 
value is <125 ml and the not normal>125 ml. 
However, other study argued that epicardial 
fat has a role in atherosclerosis, an increase 
in epicardial fat volume has a relationship 
with the type of plaque without calcification 
and plaque with a mixture of calcifications 
that cause stenosis in the coronary artery 
lumen.13 The effect of epicardial fat volume on 
the degree of severe coronary artery stenosis 
mainly due to soft plaque and mix-hard plaque 
type or atherosclerosis.14
The limitation of this study is that this study 
did not include risk factors for CHD among 
patients. Furthermore, the evaluation of EFV 
and the degree of coronary artery stenosis is 
highly dependent on the operator’s ability to 
reconstruct DICOM data from cardiac CT scans
To conclude, there is a significant 
relationship between the EFV value, EFV 
category, and the type of coronary artery 
plaque in CHD patients in RCA and LCX arteries. 
However, this correlation is not observed in 
LM and LAD arteries.
Further research needs to be done with 
a greater number of subjects and vary both 
female and male patients, including the 
coverage of all adults, including other risk 
factors for CHD in patients undergoing cardiac 
CT-scan examination.
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